
Public Health
Trump’s Opioid Panel Wants More Treatment Options and Drug Courts
The commission put no dollar figure on how much it would cost to support its solutions
The commission put no dollar figure on how much it would cost to support its solutions
The treatment will be reviewed by an outside panel this week
The legislation will reshape the way FDA approves medicines
The controversial drug will be headed to the market despite risks of fainting and low blood pressure
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account